Explore Our Comprehensive Pharmaceuticals Industry Research Reports
P
2016
LAMEA Oncology/Anti-cancer Drugs Market is expected to reach $17,072.2 million by 2021, registering a CAGR of 8.6% during the forecast period 2015 - 2021. Oncology drugs are used ...
Report Code : A00719 | Pages : 108 | Category : Life Sciences
U
2022
Oncology drugs help in the prevention, diagnosis, and treatment of cancer. It includes chemotherapy drugs, hormone therapy drugs such as Tamoxifen (brand name Nolvadex), immunotherapy drugs, and other ...
Report Code : A02518 | Category : Life Sciences
U
2022
Oncology drugs include chemotherapy, hormone therapy, immunotherapy, and other drugs that are useful in the treatment of cancer. According to the CDC, 21.1 million adults were diagnosed with ...
Report Code : A02529 | Category : Life Sciences
P
2019
The China oncology drugs market was valued at $6,498.2 million in 2018 and is projected to reach $12,688.7 million by 2026, registering a CAGR of 8.7% from 2019 ...
Report Code : A04505 | Pages : 135 | Category : Life Sciences
P
2019
The Japan oncology drugs market size was accounted for $9,405 million in 2018, and is expected to reach $14,109 million by 2026, registering a CAGR of 5.2% from 2019 to 2026.
Report Code : A05277 | Pages : 147 | Category : Life Sciences
P
2022
North America Gynecological Cancer Drugs Market to showcase promising growth throughout the projection period from 2021 and 2030 owing to increased spending from emerging countries.
Report Code : A25912 | Category : Life Sciences
P
2022
Therapeutic Modality segment is projected to be the dominating segment during the forecast period. The report offers an elaborate analysis on detailed impacts on the Canada Gynecological Cancer Drugs Market due to the outbreak of COVID-19.
Report Code : A25913 | Category : Life Sciences
P
2022
In market Therapeutic Modality, Targeted Therapy holds the largest revenue share during the analysis period and Therapeutic Modality is expected to exhibit the highest CAGR over the analysis period.
Report Code : A25914 | Category : Life Sciences
P
2022
Therapeutic Modality segment is projected to be the dominating segment during the forecast period. The report offers an elaborate analysis on detailed impacts on the Mexico Gynecological Cancer Drugs Market due to the outbreak of COVID-19.
Report Code : A25915 | Category : Life Sciences
P
2022
Therapeutic Modality is projected as the most lucrative segment. The report provides insights based on the key determinants of the market, including drivers and challenges along with their relative impact on the regional and country level.
Report Code : A25916 | Category : Life Sciences
Register and Earn 500 Loyalty Points
An Email Verification Code has been sent to your email address!
Please check your inbox and, if you don't find it there, also look in your junk folder.